In ovarian serous cystadenocarcinoma, FI-net identified TP53, NF1, BRCA1, BRCA2, MUC16, CSMD3, FAT3, EGFR, RB1, CDK12, HMCN1, USH2A, CACNA1C, DST, MUC17, DNAH5, LRP2, RYR2, PRKDC, SON, GPR98, ZFYVE26, AHNAK2, GLI2, APOB, ZNF236, and ODZ1. Therein, the first 10 genes presented in the CGC database. This evidence concerns the gene GLI2 and ovarian serous cystadenocarcinoma.